Advertisement

NBTY Company Profile

14:22 EDT 22nd May 2013 | BioPortfolio

NBTY is a leading vertically integrated U.S. manufacturer and distributor of a broad line of high-quality, value-priced nutritional supplements, in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company’s Nature’s Bounty®, Vitamin World®, Puritan’s Pride®, Holland & Barrett®, Rexall®, Sundown®, MET-Rx®, WORLDWIDE Sport Nutrition®, GNC (UK)®, DeTuinen®, LeNaturiste™, SISU®, and Solgar®. For the fiscal third quarter ended June 30, 2006, net sales increased $36 million, or 8%, to $475 million, including $24 million generated by Solgar, compared to net sales of $439 million for the fiscal third quarter ended June 30, 2005. Net income for the fiscal third quarter ended June 30, 2006 was $30 million, or $0.43 per diluted share, compared to $16 million, or $0.23 per diluted share, for the fiscal third quarter ended June 30, 2005. For the nine months ended June 30, 2006, net sales increased $110 million, or 8%, to $1.4 billion, compared to net sales of $1.3 billion for the prior like period. Net income for the nine months ended June 30, 2006 was $74 million, or $1.07 per diluted share, compared to $67 million, or $0.97 per diluted share for the nine months ended June 30, 2005. At June 30, 2006, NBTY had working capital of $387 million and total assets of $1.3 billion, including $375 million in inventory. Inventory decreased $21 million for the fiscal third quarter of 2006 and decreased $117 million for the nine months ended June 30, 2006. These decreases reflect the Company’s successful initiatives to lower inventory while continuing to assure uninterrupted product supply to its customers. NBTY common stock is traded on the New York Stock Exchange (NYSE) under the symbol “NTY”.


News Articles [ 22 Associated News Articles listed on BioPortfolio]

NBTY to Webcast Presentation at Barclays High Yield Conference

RONKONKOMA, N.Y., May 17, 2013 /PRNewswire/ -- NBTY, Inc., today announced it will webcast the presentation by Michael Collins, Chief Financial Officer of NBTY, at the Barclays High Yield Bond an...

NBTY to Webcast Presentation at Bank of America Merrill Lynch Leverage Finance Conference

RONKONKOMA, N.Y., Dec. 4, 2012 /PRNewswire/ -- NBTY, Inc. today announced it will webcast the presentation by Michael Collins, Chief Financial Officer of NBTY, at the Bank of America Merrill Lync...

BRIEF-Moody's puts NBTY CFR on review for downgrade

Oct 11 (Reuters) - NBTY Inc : * Moody's places nbty's cfr on review down, assigns caa1 to holding's proposed

NBTY Moves On From U.K. Health Food Retail Misadventure

Less than four years after acquiring U.K. chain Julian Graves as a new platform for European growth, NBTY absorbs a $20 mil. charge to get rid of the subsidiary, which experienced “continuing operat...

NBTY, Inc. and Alphabet Holding Company, Inc. to Webcast Fiscal Second Quarter Conference Call

RONKONKOMA, N.Y., May 6, 2013 /PRNewswire/ -- NBTY, Inc. and Alphabet Holding Company, Inc. today announced that they will webcast a joint conference call to review their fiscal second quarter results...

NBTY, Inc. and Alphabet Holding Company, Inc. Reschedule Webcast of Fiscal Second Quarter Conference Call

RONKONKOMA, N.Y., May 7, 2013 /PRNewswire/ -- NBTY, Inc. and Alphabet Holding Company, Inc. today announced that they have rescheduled the webcast of their joint conference call to review their f...

TEXT-S&P assigns NBTY Inc notes preliminary 'B-' rating

Overview -- U.S.-based NBTY Inc. proposed today a $500 million notes issuance in order to fund an approximately $700 million investor dividend; the remainder is to be funded with cash from the...

NBTY Acquires Balance Bar To Expand In Sports Category

The acquisition from private equity firm Brynwood Partners includes four product lines under the Balance Bar brand, which NBTY claims is one of the most recognizable in the nutrition bar category, a g...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [ 2 Associated Companies listed on BioPortfolio]

NBTY, Inc.

NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the worl...

NBTY

NBTY is a leading vertically integrated U.S. manufacturer and distributor of a broad line of high-quality, value-priced nutritional supplements, in the United States and throughout the world. Under a...

More Information about "NBTY" on BioPortfolio

We have published hundreds of NBTY news stories on BioPortfolio along with dozens of NBTY Clinical Trials and PubMed Articles about NBTY for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NBTY Companies in our database. You can also find out about relevant NBTY Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement